• Kinexum LogoThis  document  has been  redacted by  Sam Collaudin, Kinexum Business Strategy  Consultant, independently  from any  pharmaceutical and  biotech companies 
  • It synthesizes  selected  data presented  during  the  ATTD 2021  conference 
  • Grey  rectangles  are  personal  comments and  opinions,  underlined  words are clickable  links  to other  slides  or  external  references 
  • If  you  have comments, please  contact me by  email (This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Disclosure: Business  strategy consultant  at Modular  Medical,  CEO  of Abvance Kinexum ,  consultant  for Therapeutics, chairman  of  a non  for profit French health  care  insurance company  (Groupe Operating  Since  2003 Uitsem)